Predictors of Target Lesion Revascularization in Patients Undergoing Lower Extremity Percutaneous Interventions
Overview
Affiliations
Background: Predictors of target lesion revascularization (TLR) have not been well defined in patients undergoing peripheral percutaneous interventions (PPI). In this study we analyze predictors of TLR in a consecutive cohort of patients from two medical centers.
Methods: Data were extracted from a prospectively collected peripheral vascular registry. Of 105 consecutive patients (175 vessels) undergoing PPI, follow up was achieved in 104 patients (172 vessels) at 8.06 +/- 4.51 months. Univariate analysis was performed between the groups with (n = 19, vessels = 25) and without (n = 85, vessels = 147) TLR. Logistic regression analysis was utilized to model for the predictors of TLR.
Results: TLR occurred in 14% of vessels treated at 8.06 +/- 4.51 months. By univariate analysis, vessels with TLR on follow up had longer treated segments (167.0 +/- 139.16 mm vs. 98.49 +/- 113.33 mm; p = 0.027), more severe lesions (91.96 +/- 12.56% vs. 85.51 +/- 14.43%; p = 0.037) and were younger (63.0 +/- 10.1 years vs. 69.1 +/- 11.1 years; p = 0.032). Also, there was a trend toward a higher hs-CRP (11.35 +/- 17.85 vs. 7.45 +/- 9.57 mg/L) and more total occlusions (44.0% vs. 22.6%) in the TLR group, but these did not reach statistical significance. Logistic regression analysis with backward elimination including all these variables showed that younger age (p = 0.007), female gender (p = 0.033) and treated vessel length (p = 0.028) were the only independent predictors of TLR.
Conclusions: Younger age, female gender and longer treated vessel length are independent predictors of TLR in patients undergoing PPI. The cost-effectiveness in treating these patients with PPI versus surgery needs to be defined in future studies.
Chai D, Yang X, Wang A, Lu S, Dai Y, Zhou J Front Cardiovasc Med. 2022; 9:710804.
PMID: 35387442 PMC: 8977890. DOI: 10.3389/fcvm.2022.710804.
Shu X, Li Z, Chang Y, Liu S, Wang W, Li X Exp Ther Med. 2018; 15(3):2874-2878.
PMID: 29456691 PMC: 5795511. DOI: 10.3892/etm.2018.5751.
Schroeder H, Meyer D, Lux B, Ruecker F, Martorana M, Duda S Catheter Cardiovasc Interv. 2015; 86(2):278-86.
PMID: 25708850 PMC: 6585947. DOI: 10.1002/ccd.25900.
Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention.
Lupi A, Secco G, Rognoni A, Rossi L, Lazzero M, Nardi F J Thromb Thrombolysis. 2011; 33(4):308-17.
PMID: 21909639 DOI: 10.1007/s11239-011-0628-z.